Known for its iconic thick soled boots in every colour you could imagine, Dr. Martens (DOCS) sells footwear that's built to last and stylish too. After more than 60 years of trading, it decided to float on the London Stock Exchange in January 2021.
Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.
Quantity of shares
| Platform | Finder score | Account fee | Min. initial deposit | Trade cost | Link |
|---|---|---|---|---|---|
 |
4.39 ★★★★★ |
£0 | $100 | £734.29 |
Go to siteCapital at risk
|
 |
3.75 ★★★★★ |
0.12% per year | £0 | £810.64 |
Go to siteCapital at risk
|
 |
4.3 ★★★★★ |
£0 | £0 | £730.64 |
Go to siteCapital at risk
|
 |
4.2 ★★★★★ |
£0 | £1 | £742.59 |
Go to siteCapital at risk
|
 |
4.34 ★★★★★ |
0% - 0.25% | £100 | £730.64 |
Go to siteCapital at risk
|
 |
4.1 ★★★★★ |
£0 | £0 | N/A |
Read reviewCapital at risk
|
 |
4.4 ★★★★★ |
£0 | £0 | £730.64 |
Read reviewCapital at risk
|
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Dr. Martens), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Dr. Martens is a major part of the London stock exchange, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
April 16, 2024: Dr Martens' share price has plunged by more than 30% in the past week and trading was temporarily paused on the London Stock Exchange. This comes after the shoemaker highlighted tough times ahead with weaker revenues and the current CEO stepping down.
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Over the last 12 months, Dr. Martens's shares have ranged in value from as little as 62 up to 166.0969. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Dr. Martens's is -0.03. This would suggest that Dr. Martens's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Dr. Martens has bucked the trend.
Historical closes compared with the last close of 72.7
| 1 week (2024-04-18) | 8.02% |
|---|---|
| 1 month (2024-03-27) | -17.15% |
| 3 months (2024-01-25) | -17.39% |
| 6 months (2023-10-26) | -36.78% |
| 1 year (2023-04-27) | -56.23% |
| 2 years (2022-04-27) | -65.45% |
| 3 years (2021-04-27) | -83.95% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Dr. Martens P/E ratio, PEG ratio and EBITDA
Dr. Martens's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Dr. Martens shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the United Kingdom stock market as of 09 November, 2023 (10). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Dr. Martens's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.
Dr. Martens's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.6735. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Dr. Martens's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Dr. Martens's PEG ratio in relation to those of similar companies.
Dr. Martens's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £182.2 million.
The EBITDA is a measure of a Dr. Martens's overall financial performance and is widely used to measure a its profitability.
To put that into context you can compare it against similar companies.
Sign up for weekly expert share tips
Join 100,000 subscribers who are notified about expert share tips. Plus a chance to win £800!
By signing up you agree to receive emails from Finder and to the privacy policy and terms & conditions.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Footwear stocks can be rewarding, but there are risks involved that could impact your profits.
Ever wondered how to buy shares in Ralph Lauren? We explain how and compare a range of providers that can give you access to many brands, including Ralph Lauren.
Ever wondered how to buy shares in Watches of Switzerland Group? We explain how and compare a range of providers that can give you access to many brands, including Watches of Switzerland Group.
Ever wondered how to buy shares in TJX? We explain how and compare a range of providers that can give you access to many brands, including TJX.
Ever wondered how to buy shares in Nike? We explain how and compare a range of providers that can give you access to many brands, including Nike.
Find out how to buy shares in Superdry, see its share prices over the last three months and check out our must-do checklist if you’re looking to invest.
Find out how to buy shares in Next, see Next’s share prices over the last three months and check out our must-do checklist if you’re looking to invest.
We walk you through buying shares in JD Sports, giving you a look at its share price history. See our checklist for anyone looking to invest too.
Ever wondered how to buy shares in Burberry? We explain how and compare a range of providers that can give you access to many brands, including Burberry.
Thinking about buying shares in online retail giant ASOS? We explain how to do it and run through a useful checklist for anyone looking to invest.